Navigation Links
McKool Smith Adds Noted Litigator in New York
Date:7/7/2008

Klein brings major IP and business litigation experience

NEW YORK, July 7 /PRNewswire/ -- McKool Smith, PC, one of the country's leading intellectual property and commercial litigation trial firms, is expanding its New York office with the addition of accomplished litigation attorney Gayle Rosenstein Klein.

Ms. Klein joins McKool Smith as a principal and brings broad experience representing companies and boards of directors in intellectual property disputes, complex business litigation and sensitive internal investigations.

Ms. Klein represents clients in state and federal courts and arbitration proceedings across the country. She has worked on cutting-edge legal issues involving class actions, trade secrets in high-tech and commercial business settings, and false advertising relating to consumer products. In these matters, Ms. Klein has experience leading teams of professionals to meet both legal and business strategies under high-stress circumstances.

In addition to her crisis management expertise, Ms. Klein also has represented major healthcare providers and other large businesses in breach of contract proceedings, and ERISA and breach of fiduciary duty litigation. Companies and corporate audit committees have sought out Ms. Klein to lead their sensitive options investigations and advise company executives.

Ms. Klein graduated with honors from the University of Texas School of Law. She earned her bachelor's degree with high honors from the University of Texas. Prior to joining McKool Smith, Ms. Klein was a partner at Weil, Gotshal & Manges LLP. Her addition continues McKool Smith's major expansion of its New York offices, which opened last year.

"Our intellectual property and business litigation work is growing rapidly in New York, and the addition of Gayle will help us meet the demand," says firm co-founder Mike McKool. "Our success is in large part due to the quality of our attorneys, and Gayle certainly fits the mold as an extremely talented and accomplished lawyer."

McKool Smith has more than 95 attorneys in Dallas, Austin, Marshall, New York and Washington, D.C., handling commercial and intellectual property litigation for national and international clients. The firm is recognized as one of the premier litigation law firms in the United States, having earned significant courtroom victories for clients such as American Airlines, BearingPoint, Ericsson, Electronic Data Systems, Lockheed Martin, Medtronic Inc., and Sony Ericsson.

For more information, please contact Bruce Vincent at 800-559-4534 or bruce@androvett.com.


'/>"/>
SOURCE McKool Smith, PC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
2. AUDIO from Medialink and GlaxoSmithKline: Fiber Key in Managing Irritable Bowel Syndrome (IBS) Symptoms
3. Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
4. GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program
5. KGI and Smith College Establish Leadership Forum for Women in Bioscience
6. GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry
7. Orchid Cellmark Appoints James F. Smith Chief Financial Officer
8. Dennis L. Smith Appointed Executive Chairman to Board of Directors of Solstice Neurosciences, Inc.
9. BioWa Announces Licensing of BioWas POTELLIGENT(R) Technology by GlaxoSmithkline for Use in Antibody Research and Development
10. GlaxoSmithKline Consumer Healthcare Recommends Maintaining FDAS Current Two-Class Drug System
11. GlaxoSmithKline Responds to JAMA Article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... 2017 MiMedx Group, Inc. (NASDAQ: MDXG), the ... tissue allografts and patent-protected processes to develop and market ... announced today  that it will present at the Needham ... NY.  Parker H. "Pete" Petit, Chairman and CEO, ... M. Cashman , EVP and Chief Commercialization Officer, and ...
(Date:3/24/2017)... VILLAGE, Calif. , March 24, 2017   ... dermatology and aesthetics company, today announced that Richard ... Officer, effective March 24.   Peterson, who brings ... succeed John Smither , who is retiring at ... Sienna in an advisory capacity. Peterson joins Sienna from ...
(Date:3/23/2017)... BETHESDA, Md. , March 23, 2017 /PRNewswire/ ... company developing DCVax® personalized immune therapies for solid ... on the $7.5 million financing it announced last ... Company sold to several institutional investors securities totaling ... $.26 per share, and 10,000,000 shares of Class ...
(Date:3/23/2017)... , March 23, 2017 Kineta, ... development of novel therapies in immuno-oncology, today announced ... lead" small molecule compounds that activate interferon response ... pathways and demonstrate immune-mediated tumor regression in a ... the study who demonstrated complete tumor regression to ...
Breaking Biology Technology:
(Date:3/2/2017)... Summary This report provides all ... and its partnering interests and activities since 2010. ... The Partnering Deals and Alliance since 2010 report provides ... of the world,s leading life sciences companies. ... ensure inclusion of the most up to date deal ...
(Date:2/28/2017)... 28, 2017   Acuant , a leading provider ... significant enhancements to new and core technologies building upon ... include mobile and desktop Acuant FRM TM facial ... a real time manual review of identity documents by ... the fastest and most accurate capture software to streamline ...
(Date:2/26/2017)... Feb. 25, 2017  Securus Technologies, a leading ... for public safety, investigation, corrections and monitoring, announces ... Reentry. "Too often, too many offenders ... county jails are trying to tackle this ongoing ... friends and family members. While significant steps are underway, ...
Breaking Biology News(10 mins):